Drug intelligence / Profile preview

magnesium citrate (Protina Pharmazeutische GmbH)

Development stage
Unknown
Lead developer
Protina
Modality
Small Molecules
Administration
Oral
01

Overview

Magnesium Extra is an oral magnesium supplement developed by Protina Pharmazeutische GmbH, specifically associated with the Magnesium-Diasporal 400 EXTRA product line. The active ingredient is trimagnesium dicitrate (magnesium citrate), a form of magnesium noted for its high biocompatibility. The supplement is used to maintain magnesium ion (Mg2+) homeostasis, which plays a critical role in vascular smooth muscle relaxation and blood pressure regulation. In clinical research, Magnesium Extra has been evaluated in randomized, double-blind, placebo-controlled trials to determine whether daily oral magnesium supplementation can prevent blood pressure increases and gestational hypertension in healthy first-time pregnant women.

Brand names
Magnesium ExtraMagnesium-Diasporal 400 EXTRAMagnesium-Diasporal400 EXTRAMagnesium-Diasporal-400 EXTRA
Other names
trimagnesium dicitratemagnesium dicitrate
02

Targets

MG (Mycoplasma gallisepticum)

Beyond the preview

Go deeper on magnesium citrate (Protina Pharmazeutische GmbH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium citrate (Protina Pharmazeutische GmbH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call